GRN and torsades de pointes: First, we carried out dose-response experiments to evaluate the influence of increasing concentrations of two N-benzothiazolyl-2-phenyl-acetamides derivatives (IGS-2.7 and IGS-3.27) on viability of lymphoblasts from control and carriers of GRN mutation, asymptomatic and FTLD-TDP patients.